Loading patent…
AssigneeThe United States of America as represented by the Department of Health and Human Services
InventorsGerald J. Chader, S. Patricia Becerra, Joyce Tombran-Tink, Lincoln V. Johnson, Fintan R. Steele, Ignacio Rodriguez
Estimating the term…
Nucleic acids encoding the neurotrophic protein known as pigment epithelium-derived factor (PEDF), a truncated version of PEDF referred to as rPEDF, and equivalent proteins, vectors comprising such nucleic acids, host cells into which such vectors have been introduced, recombinant methods for producing PEDF, rPEDF, and equivalent proteins, the rPEDF protein and equivalent proteins of rPEDF and PEDF-BP, -BX and BA, and the PEDF protein produced by recombinant methods. Effects and uses of these variants on 1) neuronal differentiation (neurotrophic effect) 2) neuron survival (neuronotrophic effect) and 3) glial inhibition (gliastatic effect) are described.
A recombinant PEDF protein consisting of SEQ ID NO:2 having PEDF biological activity and free from other human proteins.
A seventy-seven amino acid PEDF protein defined by amino acids 44-121 of SEQ ID NO:2 and encoded by a nuclcic acid that consists of nucleotide residues 266-499 of SEQ ID NO:1 produced in accordance with the method comprising the steps of:
An isolated and purified PEDF protein wherein the PEDF protein consists of SEQ ID NO:3 and has PEDF biological activity.
An isolated and purified PEDF protein wherein the PEDF protein consists of amino acids 44 through 269 of SEQ ID NO:2 and has PEDF biological activity.
An isolated and purified PEDF protein wherein the PEDF protein consists of amino acids 44 through 227 of SEQ ID NO:2 and has PEDF biological activity.
An isolated and purified PEDF protein wherein the PEDF protein consists of amino acids 44 through 121 of SEQ ID NO:2 and has PEDF biological activity.
Dependencies are inferred from the claim text.